Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Donna Bannavong"'
Autor:
Takuya Osada, Erica Browning, Erika Crosby, Hiroshi Nagata, Melinda Telli, Chaitanya Acharya, Irene Wapnir, Kaitlin Zablotsky, Reneta Hermiz, Lauren Svenson, Donna Bannavong, Kellie Malloy, David Canton, Christopher Twitty, Herbert Lyerly
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/c561f28698a24467bc51a278cfc482d2
Autor:
Erika J. Crosby, H. Kim Lyerly, Takuya Osada, Christopher G. Twitty, David A. Canton, Kellie Malloy Foerter, Jendy Sell, Kim Jaffe, Donna Bannavong, Lauren Svenson, Reneta Hermiz, Erica Browning, Robert H. Pierce, Mai Hope Le, Carmen Ballesteros-Merino, Shawn M. Jensen, Carlo B. Bifulco, Bernard A. Fox, Kaitlin Zablotsky, Chaitanya R. Acharya, Irene Wapnir, Hiroshi Nagata, Melinda L. Telli
Figure S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44a596ca06ec554d854aa13d403d5a24
https://doi.org/10.1158/1078-0432.22484048
https://doi.org/10.1158/1078-0432.22484048
Autor:
Adil I. Daud, Michael D. Rosenblum, Bernard A. Fox, Robert H.I. Andtbacka, Sharron Gargosky, Shailender Bhatia, Carmen Ballesteros-Merino, Carlos Bifulco, Lauren P. Levine, Christopher Garris, Sean P. Arlauckas, Mikael J. Pittet, Lawrence Fong, Murray Francisco, Arielle Oglesby, Donna Bannavong, David A. Canton, Reneta Hermiz, Erica Browning, Robert Pierce, Mai Le, Katy K. Tsai, Christopher G. Twitty, Alain P. Algazi
Treatment related changes in cell type scores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2dab53da92d4304d25e1a122adb363
https://doi.org/10.1158/1078-0432.22477617
https://doi.org/10.1158/1078-0432.22477617
Autor:
Adil I. Daud, Michael D. Rosenblum, Bernard A. Fox, Robert H.I. Andtbacka, Sharron Gargosky, Shailender Bhatia, Carmen Ballesteros-Merino, Carlos Bifulco, Lauren P. Levine, Christopher Garris, Sean P. Arlauckas, Mikael J. Pittet, Lawrence Fong, Murray Francisco, Arielle Oglesby, Donna Bannavong, David A. Canton, Reneta Hermiz, Erica Browning, Robert Pierce, Mai Le, Katy K. Tsai, Christopher G. Twitty, Alain P. Algazi
Purpose:Tumors with low frequencies of checkpoint positive tumor-infiltrating lymphocytes (cpTIL) have a low likelihood of response to PD-1 blockade. We conducted a prospective multicenter phase II trial of intratumoral plasmid IL-12 (tavokinogene te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddd2c239e09f2d5a2524c8e57f19d8f4
https://doi.org/10.1158/1078-0432.c.6529707.v1
https://doi.org/10.1158/1078-0432.c.6529707.v1
Autor:
Adil I. Daud, Michael D. Rosenblum, Bernard A. Fox, Robert H.I. Andtbacka, Sharron Gargosky, Shailender Bhatia, Carmen Ballesteros-Merino, Carlos Bifulco, Lauren P. Levine, Christopher Garris, Sean P. Arlauckas, Mikael J. Pittet, Lawrence Fong, Murray Francisco, Arielle Oglesby, Donna Bannavong, David A. Canton, Reneta Hermiz, Erica Browning, Robert Pierce, Mai Le, Katy K. Tsai, Christopher G. Twitty, Alain P. Algazi
Lesion response data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940014a570fe99ab1b99be080965c229
https://doi.org/10.1158/1078-0432.22477605.v1
https://doi.org/10.1158/1078-0432.22477605.v1
Autor:
Erika J. Crosby, H. Kim Lyerly, Takuya Osada, Christopher G. Twitty, David A. Canton, Kellie Malloy Foerter, Jendy Sell, Kim Jaffe, Donna Bannavong, Lauren Svenson, Reneta Hermiz, Erica Browning, Robert H. Pierce, Mai Hope Le, Carmen Ballesteros-Merino, Shawn M. Jensen, Carlo B. Bifulco, Bernard A. Fox, Kaitlin Zablotsky, Chaitanya R. Acharya, Irene Wapnir, Hiroshi Nagata, Melinda L. Telli
Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ca7169c9f34582371ebebd076f3eb7
https://doi.org/10.1158/1078-0432.22484039
https://doi.org/10.1158/1078-0432.22484039
Autor:
Adil I. Daud, Michael D. Rosenblum, Bernard A. Fox, Robert H.I. Andtbacka, Sharron Gargosky, Shailender Bhatia, Carmen Ballesteros-Merino, Carlos Bifulco, Lauren P. Levine, Christopher Garris, Sean P. Arlauckas, Mikael J. Pittet, Lawrence Fong, Murray Francisco, Arielle Oglesby, Donna Bannavong, David A. Canton, Reneta Hermiz, Erica Browning, Robert Pierce, Mai Le, Katy K. Tsai, Christopher G. Twitty, Alain P. Algazi
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25d0cab47894d2b34b9067e043e1f48c
https://doi.org/10.1158/1078-0432.22477611.v1
https://doi.org/10.1158/1078-0432.22477611.v1
Autor:
Erika J. Crosby, H. Kim Lyerly, Takuya Osada, Christopher G. Twitty, David A. Canton, Kellie Malloy Foerter, Jendy Sell, Kim Jaffe, Donna Bannavong, Lauren Svenson, Reneta Hermiz, Erica Browning, Robert H. Pierce, Mai Hope Le, Carmen Ballesteros-Merino, Shawn M. Jensen, Carlo B. Bifulco, Bernard A. Fox, Kaitlin Zablotsky, Chaitanya R. Acharya, Irene Wapnir, Hiroshi Nagata, Melinda L. Telli
Supplementary methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b225ca75afa3d921ee14dfdf27630e8
https://doi.org/10.1158/1078-0432.22484042
https://doi.org/10.1158/1078-0432.22484042
Autor:
Erika J. Crosby, H. Kim Lyerly, Takuya Osada, Christopher G. Twitty, David A. Canton, Kellie Malloy Foerter, Jendy Sell, Kim Jaffe, Donna Bannavong, Lauren Svenson, Reneta Hermiz, Erica Browning, Robert H. Pierce, Mai Hope Le, Carmen Ballesteros-Merino, Shawn M. Jensen, Carlo B. Bifulco, Bernard A. Fox, Kaitlin Zablotsky, Chaitanya R. Acharya, Irene Wapnir, Hiroshi Nagata, Melinda L. Telli
Purpose:Triple-negative breast cancer (TNBC) is an aggressive disease with limited therapeutic options. Antibodies targeting programmed cell death protein 1 (PD-1)/PD-1 ligand 1 (PD-L1) have entered the therapeutic landscape in TNBC, but only a minor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e551cda28c1fd25f0ef23972aa309b8
https://doi.org/10.1158/1078-0432.c.6531311.v1
https://doi.org/10.1158/1078-0432.c.6531311.v1
Autor:
Melinda L. Telli, Irene Wapnir, Bianca Devitt, Katharine Cuff, Hatem Soliman, Shaveta Vinayak, David A. Canton, Christopher G. Twitty, Sunny Xie, Ying Lu, Donna Bannavong, Bridget O'Keeffe, Sandra Aung, Rohit Joshi
Publikováno v:
Cancer Research. 82:P2-14
BACKGROUND: Electroporated plasmid interleukin-12 (tavokinogene telseplasmid; TAVO-EP) delivered to accessible tumors by intratumoral injection induces sustained local expression of IL-12. IL-12 is a potent immunoregulatory cytokine that plays a key